Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03631251 · ClinicalTrials.gov registry record · Early Phase 1

Using Honest Placebos to Improve Pain Management in Hand Surgery Patients

A Early Phase 1 study, sponsored by Brown University.

Completed
Registry status
Early Phase 1
Development phase
10
Enrollment target

NCT03631251: Completed Early Phase 1 study, sponsored by Brown University.

NCT03631251 is a Early Phase 1 study that has completed, run by Brown University. The registered enrollment target is 10 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03631251, a Early Phase 1 study, has completed, sponsored by Brown University.

COMPLETED
Registry status
Early Phase 1
Development phase
10 participants
Enrollment target

Study Summary

America is in the midst of an opioid epidemic. One of the reasons opioid addiction and overdose deaths have recently increased is that doctors are frequently prescribing opioid medication as a treatment for pain. If it is possible to develop new ways of increasing the pain-relief patients experience from a set amount of opioids, then doctors might ultimately be able to prescribe fewer opioid medications, which could help curb the opioid crisis. Although "placebos," a medication whose benefit derives solely from positive psychological factors rather than pharmacological factors, are often disparaged in medicine, research suggests that placebos can actually help reduce pain. In fact, there is reason to think that placebos are effective even when a patient knows they are taking a placebo. The goal of the proposed study is to examine the feasibility of using an honest placebo to relieve pain for up to 20 real patients. People who are undergoing hand or wrist surgery or enrolled for upper extremity trauma in the Emergency Department and agree to participate will be asked to take placebo pills in addition to their standard course of opioid pills, given as part of standard care. Patients will also answer a few short questions over the phone once per day for seven days, and be invited to participate in an exit questionnaire at the end of the study. The investigators hypothesize that: 1) At least 50% of eligible participants will agree to enroll, 2) At least 80% of participants who are enrolled will be retained, and 3) Participants who are enrolled will take a placebo at least 50% of the time they also take an opioid pill

Primary Outcome

Percentage of Eligible Patients who Enroll

Interventions

  • DRUG Open Placebo

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-08-17
Est. Completion 2019-07-15
Phase Early Phase 1
Brown University

231 total trials

What the finished NCT03631251 record still lists

NCT03631251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (81% lower).

The record links to 0 conditions, and to 1 intervention - of which Open Placebo is the first listed.

NCT03631251 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03631251 about?

NCT03631251 is a clinical study titled "Using Honest Placebos to Improve Pain Management in Hand Surgery Patients". America is in the midst of an opioid epidemic. One of the reasons opioid addiction and overdose deaths have recently increased is that doctors are frequently prescribing opioid medication as a treatment for pain. If it is possible to develop new ways of increasing the pain-relief patients experience...

What is the current status of trial NCT03631251?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 10 participants. The study started on 2018-08-17. Estimated completion is 2019-07-15.

What interventions are being tested in trial NCT03631251?

The interventions under investigation include: Open Placebo (DRUG).

Who is sponsoring clinical trial NCT03631251?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03631251's enrollment target sits among peer trials

10 1629th of 2000 higher than 256 of 2,000 other Early Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03631251, the US trial registry maintained by the National Library of Medicine. NCT03631251 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.